FGF21 and metabolic dysfunction-associated steatotic liver disease: FGF21 can protect against NAFLD/NASH by reducing hepatocyte stress and hepatic steatosis as well as directly protecting against inflammation and fibrosis, which is aimed at the pathological characteristics of NAFLD/NASH.